Showing 1 to 1 of 1 results
forbes.com
🌐 85% Global Worthiness
Congress Weighs Reauthorization of Life-Saving Pediatric Drug Incentive Program
Congress can reauthorize the expired Pediatric Priority Review Voucher (PPRV) program to incentivize pharmaceutical companies to develop treatments for rare pediatric diseases without taxpayer costs; the program has already facilitated the approval of 50 life-saving treatments for 40 diseases.
Congress Weighs Reauthorization of Life-Saving Pediatric Drug Incentive Program
Congress can reauthorize the expired Pediatric Priority Review Voucher (PPRV) program to incentivize pharmaceutical companies to develop treatments for rare pediatric diseases without taxpayer costs; the program has already facilitated the approval of 50 life-saving treatments for 40 diseases.
Progress
52% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results